⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
7MM Metabolic Dysfunction-Associated Steatohepatitis Drug Analysis and Forecast Report 2022-2032: Growth Driven by GLP-1RA Launches Such as Semaglutide and Rising Adoption of Non-Invasive Diagnostics
globenewswire.com
MRVL
NVO
Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mg
prnewswire.com
NVO
Chemotherapy-induced Peripheral Neuropathy Treatment Market Poised for Strong Growth Throughout the Forecast Period (2025–2034) Amid Rising Chemotherapy Adoption | DelveInsight
globenewswire.com
WEX
ATX
ASMF
VELO
WSNT
LEX
VRTX
PFE
REGN
LLY
GSK
NVO
ISPC
MRK
SCIX
Zealthy Under Review: The 2025 Doctor-Led GLP-1 Weight Loss Program That's Changing the Industry
accessnewswire.com
NVO
LLY
Team Novo Nordisk confirms ten rider Development Team for 2026
prnewswire.com
NVO
Chronic Heart Failure Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight
globenewswire.com
CYTK
BAYRY
LLY
BCDA
MESO
TNSA
NVO
AZN
BMY
ITCI
JNJ
AMGN
ARWR
Novo Nordisk phase 2 trial with amycretin reports significant weight loss and HbA1c reduction in type 2 diabetes
globenewswire.com
NVO
Readout of Phase 3 Semaglutide Trials Marks Critical Moment in Alzheimer's Research and Suggests Potential for Combination Therapies
prnewswire.com
NVO
GEHC
Insulin Delivery Devices Market Surges to USD 43.11 Billion by 2033 as Smart Pumps, Automated Systems & Digital Diabetes Management Transform Patient Care
prnewswire.com
NVO
SNY
LLY
MDT
INSY
TNDM
More Muscle, Less Belly Fat Slows Brain Aging
prnewswire.com
NVO